Procedures for Health Risk Assessment in Europe

By Seeley M.R.   Tonner-Navarro L.E.   Beck B.D.   deskin R.   Feron V.J.   Johanson G.   Bolt H.M.  

Regulatory Toxicology and Pharmacology, Vol. 34, Iss. 2, 2001-10 ,pp. : 153-169

Academic Press

Access to resources Recommend Favorite

A Unified Approach to Risk Assessment for Cancer and Noncancer Endpoints Based on Benchmark Doses and Uncertainty/Safety Factors1

By Gaylor D.W.   Kodell R.L.   Chen J.J.   Krewski D.  

Regulatory Toxicology and Pharmacology, Vol. 29, Iss. 2, 1999-04 ,pp. : 151-157

Academic Press

Access to resources Recommend Favorite

A New Model Function for Continuous Data Sets in Health Risk Assessment of Chemicals Using the Benchmark Dose Concept

By Kalliomaa K.   Haag-Grönlund M.   Victorin K.  

Regulatory Toxicology and Pharmacology, Vol. 27, Iss. 2, 1998-04 ,pp. : 98-107

Academic Press

Access to resources Recommend Favorite

INVESTIGATION OF THE POTENTIAL IMPACT OF BENCHMARK DOSE AND PHARMACOKINETIC MODELING IN NONCANCER RISK ASSESSMENT

By Clewell Harvey J.   Gentry P. Robinan   Gearhart Jeffery M.  

Journal of Toxicology and Environmental Health, Vol. 52, Iss. 6, 1997-12 ,pp. : 475-515

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Aprotinin in Cardiac Surgical Procedures

By Dobkowski W.B.   Murkin J.M.  

Drug Safety, Vol. 18, Iss. 1, 1998-01 ,pp. : 21-41

Adis International

Access to resources Recommend Favorite